#2 Understanding Hydrea: A Key Drug in Managing Resistant Chronic Myeloid Leukemia

Hydrea, also known as Hydroxyurea, is a vital medicine used in the treatment of resistant Chronic Myeloid Leukemia (CML). CML is a type of blood cancer that starts in the bone marrow and affects white blood cells. When standard treatments like tyrosine kinase inhibitors (TKIs) stop working, Hydrea can help control the disease. Hydrea works by slowing the growth of cancer cells in the blood and bone marrow. It helps reduce the high number of white blood cells, easing symptoms like fatigue, fever, and pain. This makes the patient feel better and improves their quality of life. Read more: https://www.specialitymedz.com/product/hydrea/